Meeting
2023 ASCO Annual Meeting
Optimal number of lymph node stations associated with improved survival among patients with non-small cell lung cancer (NSCLC).
Authors
Meredith Ray
University of Memphis, School of Public Health, Memphis, TN
Meredith Ray , Anberitha T Matthews , Olawale Akinbobola , Matthew Smeltzer , Carrie Fehnel , Nicholas R Faris , Andrea Saulsberry , Kourtney Dortch , Samuel Muhit , Raymond U. Osarogiagbon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8571)
DOI
10.1200/JCO.2023.41.16_suppl.8571
Abstract #
8571
Poster Bd #
198
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Quality Care Symposium
Survival as a measure of quality of cancer care and advances in therapy: Lessons learned from analyses of the National Cancer Data Base (NCDB).
First Author: Lawrence N. Shulman
Poster
2014 ASCO Annual Meeting
Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts).
First Author: Alice K Fortune-Greeley
Poster
2013 ASCO Annual Meeting
Survival of non-small cell lung cancer (NSCLC) patients with and without diabetes mellitus (DM): Findings from the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS).
First Author: Taher Abu Hejleh
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray